Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Don S.Boller who wrote (245)	9/23/1998 3:42:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3044

Don: You're an ex-broker, an ex-salesman. Given your perspective, it is not surprising that you consider opportunities to make more money to be good opportunities. I am a scientist. The biotech sector came into being to develop technologies that are competitive with those of pharma. Those technologies have provided, and will provide, innovative medicines. The sector and those therapies are largely dependent on monies derived from public offerings. I do not appreciate that dogma is dictated by the same idiots that couldn't differentiate an AMGN from a LIPO, that an entire sector and valuable medicines have been endangered due to face-saving. I am pleased that you have an opportunity to make money. >> Gimme a break, did you just discover the stock market in the last two years??????? << No.